City
Epaper

WHO grants approval to Covaxin for emergency use listing

By ANI | Updated: November 3, 2021 17:50 IST

The World Health Organisation (WHO), has granted approval for Emergency Use Listing (EUL) for Hyderabad-based Bharat Biotech's COVID-19 vaccine, Covaxin.

Open in App

The World Health Organisation (WHO), has granted approval for Emergency Use Listing (EUL) for Hyderabad-based Bharat Biotech's COVID-19 vaccine, Covaxin.

Earlier, the WHO panel had sought additional clarifications from the manufacturer of Covaxin, in order to conduct a final EUL risk-benefit assessment for global use of the vaccine.

The approval was done on the recommendation of the Technical Advisory Group (TAG) for Emergency Use Listing (TAG-EUL), an independent advisory panel that provides recommendations to WHO on whether a Covid19 vaccine can be listed for emergency use under the EUL procedure.

Covaxin has demonstrated 77.8 per cent effectiveness against symptomatic COVID-19 and 65.2 per cent protection against the new Delta variant. Bharat Biotech said that it concluded the final analysis of Covaxin efficacy from Phase 3 trials.

Bharat Biotech's Covaxin and AstraZeneca and Serum Institute's Covishield are the two widely used vaccines in India.

Meanwhile, India's cumulative vaccination coverage crossed 107 crore.

The WHO has so far approved Covid-19 vaccines of Pfizer-BioNTech, AstraZeneca-SK Bio/Serum Institute of India, Johnson 7 Johnson - Janssen, Moderna, and Sinopharm for emergency use.

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Bharat Biotech InternationalWorld Health OrganisationBharat biotech limitedBharat biotech international ltdBharat biotech companyBharat biotech internationalBharat biotech biotech
Open in App

Related Stories

Navi MumbaiNavi Mumbai: NMMC Launches Awareness Drive on World TB Day, Maharashtra Reports 10% of India's Cases

OpinionsMerchants of Death Infiltrate Hospitals

HealthWorld Mental Health Day 2024: Depression and Anxiety Cost 12 Billion Workdays Each Year, Says WHO

NationalBird Flu: WHO Confirms Second Avian Influenza A(H9N2) Case in India, Detected in West Bengal

NationalCovaxin-Developer Bharat Biotech Amid Reports on AstraZeneca Vaccine, Says ‘Safety Is Primary Focus for All Our Vaccines’

International Realted Stories

InternationalShake Hand Forum: India, Hokkaido strengthen ties in Tokyo

InternationalPakistan conducts military drills to showcase combat readiness, appoints ISI boss as NSA

InternationalRajnath Singh speaks with US counterpart Pete Hegseth

InternationalUyghur scholar demands action against China's 'genocide' and slave labour

International'Maybe the Largest Ever': Wildfires disrupt Israeli Independence Day